Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, Ch...
Radoff-JEC group says it holds about 7.7% of Seer shares
Radoff-JEC Group Urges Seer Stockholders to Vote “FOR” All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY | SEER Stock News
Seer urges shareholders to back board slate, reject Radoff-Torok push for early sale at July 28 vote
Seer special committee rejects CEO Farokhzad buyout proposal at $2.45 per share
Seer urges vote for board slate as Radoff-Torok group pushes early sale, cash strip ahead of July 28 meeting
Weekly Recap: Acquisition offer for Seer and shareholder vote on directors